Akari Therapeutics Plc ADR (AKTX)
Market Open
11 Aug, 15:59
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
7. 56
+0.03
+0.3838%
$
8.01M Market Cap
- P/E Ratio
- Div Yield
7,573 Volume
0 Eps
$ 7.53
Previous Close 
Want to track AKTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Akari Therapeutics Plc ADR (AKTX) Statistics
Valuation metrics
Market Cap 8.01M
Enterprise value 5.98M
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 45.75K
Average volume (90 days) 1.4M
Price summary
52-Week low 3.02
52-Week high 49.6
Beta -
50-Day moving average 10.12
200-Day moving average 8
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 31 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.83%
Return on equity -1.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1,333.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 131.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 0.27%
Book value per share (mrq) 683.46
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
